Clinical Trial Update: Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy, safety and pharmacokinetics of GSK1325760A in pulmonary arterial hypertension has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• GSK1325760A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension, Pulmonary | Phase 2 | Status: COMPLETED | Results posted: 2009-11-10